Skip to search formSkip to main contentSkip to account menu

Org 31806

Known as: Org-31806 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

EstrenesFurans

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
Org-31806 Organon NV.
  • D. C. Skinner
  • IDrugs : the investigational drugs journal
  • 1998
  • Corpus ID: 37873241
Org-31806 is a progestogen antagonist under development by Organon with potential for the treatment of cancer and menstruation… 
1997
1997
Comparative effectiveness of three antiprogestins alone and in combination with anordiol in terminating pregnancy in the rat.
1997
1997
Tonic support of luteinizing hormone secretion by adrenal progesterone in the ovariectomized monkey replaced with midfollicular phase levels of estradiol.
Although it is known that progesterone facilitates the estradiol-induced gonadotropin surge at midcycle, its effect on LH… 
1997
1997
Characterization of ligand binding, DNA binding and phosphorylation of progesterone receptor by two novel progesterone receptor antagonist ligands
In order to gain a better understanding of the distinctive mechanisms of the various types of antiprogestins, we have… 
1997
1997
Antiprogestins and iatrogenic glucocorticoid resistance.
Highly Cited
1994
Highly Cited
1994
Pharmacology of two new very selective antiprogestagens: Org 31710 and Org 31806.
Org 31710 and Org 31806 are new antiprogestagens. These compounds were tested for their binding affinity to various steroid… 
Review
1994
Review
1994
Pre-clinical and clinical treatment of breast cancer with antiprogestins.
Antiprogestins form a new potential treatment modality for breast cancer and their mode of action has been assessed in vitro on… 
1992
1992
Novel antiprogestins Org 31806 and 31710: Interaction with mammalian progesterone receptor and DNA binding of antisteroid receptor complexes
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)